资讯

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock gain as Trump administration to trial Medicare, Medicaid coverage for ...
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
U.S. President Donald Trump listens to remarks during a swearing-in ceremony for Administrator of the Centers for Medicare ...
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
The Trump administration is exploring a five-year pilot program to include weight-loss drugs like Wegovy, Ozempic, Zepbound, ...
Changes to Medicaid could leave thousands of South Dakotans uninsured and impair an already fragile rural health care system, ...
Throughout the country, pediatricians say anxious parents are concerned about access to routine childhood immunizations, ...
As changes to Medicaid funding and enrollment requirements come into effect over the next few years, the Minnesota Department ...
Trump's legislation will require more Medicaid patients to work. In two states that tried it, many lost coverage.